INNOVATOR S&P 500 ULTRA BUFFER ETF NOV UNOV 深 沪
已收盘 04-02 16:00:00 美东时间
37.4057
+0.016
+0.04%
华盛通- 最 高37.44
- 今 开37.22
- 成交量 7.30万股
- 最 低 37.22
- 昨 收 37.39
- 总市值 1.66亿
- 52周最高 38.52
- 市盈率 静 --
- 换手率 1.64%
- 52周最低 32.52
- 委 比 0.00%
- 总股本 445.00万
- 历史最高 38.52
- 量 比 1.44
- 振 幅 0.59%
- 历史最低 22.526
- 每 手 1
- 风险率 1.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Alphaton Capital Executes Binding Call Option With Immunova
BRIEF-Alphaton Capital Executes Binding Call Option With Immunova Feb 17 (Reuters) - AlphaTON Capital Corp ATON.O : ALPHATON CAPITAL EXECUTES BINDING CALL OPTION TO SELL LEGACY BIOTECH ASSET IOX THERAPEUTICS TO IMMUNOVA ALPHATON CAPITAL CORP - TO RECEIVE CASH PAYMENT AND 10% EQUITY UPON ACQUISITION
02-18 04:17
BRIEF-Immunovant Announces Pricing Of $550 Million Common Stock Financing
Dec 11 (Reuters) - Immunovant Inc IMVT.O: IMMUNOVANT ANNOUNCES PRICING OF $550 MILLION COMMON STOCK FINANCING IMMUNOVANT INC - OFFERS 26.2 MILLION SHARES AT $21.00 PER SHARE Source text: ID:nGNXb79BT ...
2025-12-11 19:42
BRIEF-Immunovia Set To Launch PancreaSure In U.S.
Aug 19 (Reuters) - Immunovia AB (publ) IMMNOV.ST: IMMUNOVIA SET TO LAUNCH PANCREASURE IN THE US ON SEPTEMBER 2ND, SHARES COMMERCIAL STRATEGY PANCREASURE TEST IS SET TO LAUNCH IN US ON SEPTEMBER 2ND So...
2025-08-19 16:42
BRIEF-Immunovant Announces Next Phase Of Growth With Roivant Including Changes To Its Leadership Team And Additional Indications
April 21 (Reuters) - Immunovant Inc IMVT.O: IMMUNOVANT ANNOUNCES NEXT PHASE OF GROWTH WITH ROIVANT INCLUDING CHANGES TO ITS LEADERSHIP TEAM AND ADDITIONAL INDICATIONS SJÖGREN’S DISEASE (SJD) AND CUTAN...
2025-04-21 19:50
BRIEF-Immunovia Announces Determined Exercise Price For Warrants Series To 3
March 27 (Reuters) - Immunovia AB (publ) IMMNOV.ST: IMMUNOVIA ANNOUNCES DETERMINED EXERCISE PRICE FOR WARRANTS SERIES TO 3 IMMUNOVIA AB (PUBL) - SETS EXERCISE PRICE FOR WARRANTS SERIES TO 3 AT SEK 0.2...
2025-03-28 04:40
BRIEF-Immunovia Initiates Search For A New CFO To Support Commercialization In The USA
Feb 21 (Reuters) - Immunovia AB (publ) IMMNOV.ST: IMMUNOVIA INITIATES SEARCH FOR A NEW CFO TO SUPPORT COMMERCIALIZATION IN THE USA IMMUNOVIA AB (PUBL) - KARIN ALMQVIST LIWENDAHL TO STEP DOWN AS IMMUNO...
2025-02-22 02:44
BRIEF-Immunovant Announces $450 Million Private Placement
Jan 13 (Reuters) - Immunovant Inc IMVT.O: IMMUNOVANT ANNOUNCES $450 MILLION PRIVATE PLACEMENT IMMUNOVANT INC - TO SELL 22.5 MILLION SHARES AT $20 EACH IN PIPE Source text: ID:nGNX6kQGgR Further compan...
2025-01-13 22:29
